Managers / Q2 2022 · view latest →
Integrity Capital Management (HK) Ltd
CIK 0001910842 · UNIT 605, 50 CONNAUGHT ROAD, CENTRAL, K3, 000 · 852 3666 9804
Reported Value
Under review
reported total failed a data-quality check
Positions
23
Filings on Record
4
2019–present window
Filed
Jul 28, 2022
original filing
Summary
Compared with Q1 2022, the fund opened 0 new positions and exited 154.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Other · 92.2% · $59,000
- Equity WRT · 7.8% · $5,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HENNESSY CAPITAL INVS CORP V | SOLD OUT | −615.4K | 0 | −$6M | $0 |
| KISMET ACQUISITION THREE COR | SOLD OUT | −53.6K | 0 | −$525,000 | $0 |
| TWELVE SEAS INVESTMENT CO II | SOLD OUT | −51.4K | 0 | −$503,000 | $0 |
| SPDR S&P 500 ETF TR | SOLD OUT | −35 | 0 | −$503,000 | $0 |
| FAR PEAK ACQUISITION CORP | SOLD OUT | −47.6K | 0 | −$473,000 | $0 |
| APOLLO STRATEGIC GROWTH CAPT | SOLD OUT | −46.5K | 0 | −$463,000 | $0 |
| NORTHERN STAR INVSTMNT CORP | SOLD OUT | −47.1K | 0 | −$461,000 | $0 |
| IBERE PHARMACEUTICALS | SOLD OUT | −46.7K | 0 | −$458,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
23 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LMF ACQUISITION OPPORTUNIT I | *W EXP 01/26/202 | 10.94% | $7,000 | 63.6K |
| 2 | GOLDENBRIDGE ACQUISITION LTD | *W EXP 10/28/202 | 10.94% | $7,000 | 81.8K |
| 3 | VENUS ACQUISITION CORPORATIO | *W EXP 04/30/202 | 9.38% | $6,000 | 107.0K |
| 4 | MODEL PERFORMANCE ACQU CORP | *W EXP 04/29/202 | 9.38% | $6,000 | 46.6K |
| 5 | PROGRESS ACQUISITION CORP | *W EXP 11/11/202 | 7.81% | $5,000 | 45.4K |
| 6 | FOXWAYNE ENTERPRIS AQSTN COR | *W EXP 01/12/202 | 7.81% | $5,000 | 84.3K |
| 7 | SRZNWAFRICAN GOLD ACQUISITION CORPhistory → | *W EXP 08/01/203 | 6.25% | $4,000 | 20.3K |
| 8 | IBERE PHARMACEUTICALS | *W EXP 03/01/202 | 4.69% | $3,000 | 38.4K |
| 9 | AGBA ACQUISITION LTD | *W EXP 05/10/202 | 4.69% | $3,000 | 88.0K |
| 10 | BRILLIANT ACQUISITION CORP | *W EXP 03/31/202 | 3.13% | $2,000 | 35.8K |
| 11 | EDOC ACQUISITION CORP | *W EXP 11/30/202 | 3.13% | $2,000 | 66.2K |
| 12 | GREENCITY ACQUISITION CORP | *W EXP 04/28/202 | 3.13% | $2,000 | 55.1K |
| 13 | MALACCA STRAITS ACQUISITION | *W EXP 06/30/202 | 3.13% | $2,000 | 46.2K |
| 14 | G&P ACQUISITION CORP | *W EXP 02/28/202 | 3.13% | $2,000 | 21.5K |
| 15 | VIVEON HEALTH ACQUISITION CO | *W EXP 99/99/999 | 1.56% | $1,000 | 27.1K |
| 16 | ADARA ACQUISITION CORP | *W EXP 02/11/202 | 1.56% | $1,000 | 3.6K |
| 17 | ACE GLOBAL BUSINESS ACQU LTD | *W EXP 02/20/202 | 1.56% | $1,000 | 29.0K |
| 18 | EVO ACQUISITION CORP | *W EXP 01/04/202 | 1.56% | $1,000 | 10.9K |
| 19 | PINE TECHNOLOGY ACQUISITN CO | *W EXP 03/31/202 | 1.56% | $1,000 | 7.8K |
| 20 | NBSTWNEWBURY STREET ACQUISITN CORhistory → | *W EXP 04/30/202 | 1.56% | $1,000 | 7.6K |
| 21 | ASTREA ACQUISITION CORP | *W EXP 01/28/202 | 1.56% | $1,000 | 6.9K |
| 22 | OCA ACQUISITION CORP | *W EXP 01/14/202 | 1.56% | $1,000 | 23.5K |
| 23 | THE MUSIC ACQUISITION CORP | *W EXP 02/05/202 | 0.00% | $0 | 4.5K |
Filing History
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.